Research Study

An Open-label, Single Centre Prospective Cohort Study to Determine the Effectiveness and Safety of Targin® for Pain Management and Opioid-induced Constipation in Patients With Spinal Cord Injury: Can we Improve Pain and Ameliorate Secondary Complications of Opioid Treatment?
Principal Investigator 
Andrei Krassioukov

Overview

Body Locations and Systems 
Spinal Cord Injury
ClinicalTrials.gov# 
NCT03179475
Status 
Recruiting
Study Start/End 
Sep 14, 2017 to Dec 31, 2019
Locations 
GF Strong Rehabilitation Centre, ICORD – Blusson Pavilion
Name/Title 
Andrea Ramirez, Clinical Research Coordinator
Phone 
604-675-8856
Email Address 
aramirez@icord.org
Purpose of Study 

The study will be investigating the effectiveness of oxycodone-naloxone (brand name Targin®) at treating chronic pain in individuals with spinal cord injury. The goal of the study is to compare the effectiveness of Targin® at treating chronic pain in individuals with sub-acute and chronic spinal cord injury compared to opioid medication that is not compounded with naloxone.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.